CAGR Value :
Global Low EEO Agarose market size was valued at USD 579 million in 2024 and is projected to reach USD 764 million by 2032, exhibiting a CAGR of 4.7% during the forecast period. While North America currently dominates the market, Asia-Pacific is expected to witness the fastest growth due to expanding biotech research infrastructure.
Report Studies :
Low EEO Agarose is a high-purity polysaccharide derivative processed from seaweed extracts, characterized by extremely low electroendosmosis (EEO) values typically below 0.10. This specialized agarose variant enables precise biomolecular separation in electrophoresis by minimizing electroosmotic flow interference, which is crucial for applications requiring high-resolution DNA/RNA fragment analysis. Its superior performance stems from rigorous purification processes that remove sulfate groups and other charged impurities.
By Types :
•Low Melting Point Type
•High Melting Point Type
By Applications :
Key Industry Players
• Thermo Fisher Scientific (U.S.)
• Merck KGaA (Germany)
• Lonza Group (Switzerland)
• Gino Biotech (China)
• Canvax Biotech (Spain)
• Cleaver Scientific (UK)
• Bio-Rad Laboratories (U.S.)
• Abbexa Ltd (UK)
• Condalab (Spain)
• Global BioIngredients (India)